已收盤 11-20 16:00:00 美东时间
-0.813
-2.07%
IRulya Therapeutics Inc., formerly Quince Therapeutics, Inc., reported its third-quarter 2026 financial results, highlighting a cash position of $105.2 million, expected to fund operations through 2028. The company advanced its LAM-001 program across three indications: Bronchiolitis Obliterans Syndrome (BOS) post lung transplant, Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD), and Sarcoidosis-Associated Pulmonary Hypert...
11-13 13:00
First-in-class SAPHNELO Pen now offers greater flexibility and convenience, reaching a wider group of patientsAstraZeneca's SAPHNELO® (anifrolumab-fnia) has been approved in the US for self-administration as a
04-27 19:14
SAP unveils cloud portfolio for European customers, prioritizing digital sovereignty and AI innovation. Offers full technology stack and on-site deployment option for maximum control and data residency.
2025-09-02 20:16
Accenture and SAP launch ADVANCE to help $5B-revenue mid-sized firms accelerate cloud adoption and digital transformation.
2025-05-21 02:41
SAP Canada launched SAP Sovereign Cloud capabilities to meet the growing demand for data sovereignty, security, and compliance.
2025-03-04 22:51